Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
31.67
+0.54 (1.73%)
Dec 20, 2024, 4:00 PM EST - Market closed
Guardant Health Employees
As of December 31, 2023, Guardant Health had 1,779 total employees, including 1,768 full-time and 11 part-time employees. The number of employees decreased by 14 or -0.78% compared to the previous year.
Employees
1,779
Change (1Y)
-14
Growth (1Y)
-0.78%
Revenue / Employee
$389,126
Profits / Employee
-$288,033
Market Cap
3.91B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ICU Medical | 14,000 |
Option Care Health | 7,802 |
Haemonetics | 3,657 |
Ultragenyx Pharmaceutical | 1,276 |
Apellis Pharmaceuticals | 706 |
ADMA Biologics | 624 |
Prestige Consumer Healthcare | 570 |
Immunovant | 207 |
GH News
- 1 day ago - Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care - Business Wire
- 2 days ago - COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics - Business Wire
- 3 days ago - Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer - Business Wire
- 12 days ago - Guardant Health to Share New Research Demonstrating Value of Liquid Biopsy Tests, Real-world Data and AI Analytics in Tailoring Treatment Approaches for Breast Cancer at 2024 San Antonio Breast Cancer Symposium - Business Wire
- 17 days ago - Guardant Health Stock Flashing Surefire ‘Buy' Signal - Forbes
- 26 days ago - Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant Reveal™ - PRNewsWire
- 5 weeks ago - Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 weeks ago - Guardant Health, Inc. (GH) Q3 2024 Earnings Call Transcript - Seeking Alpha